216 related articles for article (PubMed ID: 23010163)
1. The continuing saga of snake venom disintegrins.
Calvete JJ
Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
[TBL] [Abstract][Full Text] [Related]
2. Structure-function correlations of snake venom disintegrins.
Calvete JJ
Curr Pharm Des; 2005; 11(7):829-35. PubMed ID: 15777237
[TBL] [Abstract][Full Text] [Related]
3. Snake venom disintegrins: evolution of structure and function.
Calvete JJ; Marcinkiewicz C; Monleón D; Esteve V; Celda B; Juárez P; Sanz L
Toxicon; 2005 Jun; 45(8):1063-74. PubMed ID: 15922775
[TBL] [Abstract][Full Text] [Related]
4. NMR structure of bitistatin – a missing piece in the evolutionary pathway of snake venom disintegrins.
Carbajo RJ; Sanz L; Perez A; Calvete JJ
FEBS J; 2015 Jan; 282(2):341-60. PubMed ID: 25363287
[TBL] [Abstract][Full Text] [Related]
5. Evolution of snake venom disintegrins by positive Darwinian selection.
Juárez P; Comas I; González-Candelas F; Calvete JJ
Mol Biol Evol; 2008 Nov; 25(11):2391-407. PubMed ID: 18701431
[TBL] [Abstract][Full Text] [Related]
6. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
7. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
8. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.
Calvete JJ; Moreno-Murciano MP; Theakston RD; Kisiel DG; Marcinkiewicz C
Biochem J; 2003 Jun; 372(Pt 3):725-34. PubMed ID: 12667142
[TBL] [Abstract][Full Text] [Related]
9. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
[TBL] [Abstract][Full Text] [Related]
10. Recombinant expression of mutants of the Frankenstein disintegrin, RTS-ocellatusin. Evidence for the independent origin of RGD and KTS/RTS disintegrins.
Sanz-Soler R; Lorente C; Company B; Sanz L; Juárez P; Pérez A; Zhang Y; Jin Y; Chen R; Eble JA; Calvete JJ; Bolás G
Toxicon; 2012 Sep; 60(4):665-75. PubMed ID: 22677804
[TBL] [Abstract][Full Text] [Related]
11. Disintegrins.
McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
[TBL] [Abstract][Full Text] [Related]
13. Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2.
Calvete JJ; Marcinkiewicz C; Sanz L
J Proteome Res; 2007 Jan; 6(1):326-36. PubMed ID: 17203976
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the disintegrin heterodimer from saw-scaled viper (Echis carinatus) at 1.9 A resolution.
Bilgrami S; Yadav S; Kaur P; Sharma S; Perbandt M; Betzel C; Singh TP
Biochemistry; 2005 Aug; 44(33):11058-66. PubMed ID: 16101289
[TBL] [Abstract][Full Text] [Related]
16. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterisation of three novel disintegrin precursors from the venoms of three Atheris species: Atheris chlorechis, Atheris nitschei and Atheris squamigera.
Wang H; Chen X; Wang L; Chen W; Zhou M; Chen T; Shaw C
Toxicon; 2013 Sep; 71():31-40. PubMed ID: 23732124
[TBL] [Abstract][Full Text] [Related]
18. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
Swenson S; Costa F; Ernst W; Fujii G; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
[TBL] [Abstract][Full Text] [Related]
19. Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.
Lu X; Lu D; Scully MF; Kakkar VV
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):249-60. PubMed ID: 15974889
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
